StonvexLoading…
StonvexStonvexStonvexCore line items from BKH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $762.00M | $2.29B | $1.66B | $1.24B |
Operating Income | $201.90M | $537.50M | $366.10M | $287.40M |
Net Income | $131.00M | $291.60M | $186.60M | $161.70M |
EPS (Diluted) | $1.73 | $3.98 | $2.58 | $2.24 |
Total Assets | $10.82B | $10.87B | $10.33B | $10.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $23.60M | $182.80M | $21.10M | $8.10M |
Free Cash Flow OCF − CapEx | $-91.20M | $-146.40M | $-44.90M | $44.60M |
Shares Outstanding | 75.60M | 75.50M | 72.40M | 72.10M |